v3.26.1
Taxation - Schedule of Deferred Tax Assets (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Deferred tax assets:      
Temporary difference in accounts receivable recognition $ 5,815 $ 5,570  
Temporary difference in research and development costs 2,995 3,033  
Accrued expense 408 391  
Net operating loss carried forward 11,961 11,325  
Share-based compensation 538 295  
Allowance for credit losses 4,033 3,679  
Total deferred tax assets 25,750 24,293  
Valuation allowance (13,803) (13,840) $ (11,820)
Deferred tax assets, net of valuation allowance $ 11,947 $ 10,453